{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19203654", "DateCompleted": {"Year": "2009", "Month": "03", "Day": "03"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1016/j.jaci.2009.01.001"], "Journal": {"ISSN": "1097-6825", "JournalIssue": {"Volume": "123", "Issue": "2", "PubDate": {"Year": "2009", "Month": "Feb"}}, "Title": "The Journal of allergy and clinical immunology", "ISOAbbreviation": "J Allergy Clin Immunol"}, "ArticleTitle": "Complementary and alternative medicine for the allergist-immunologist: where do I start?", "Pagination": {"StartPage": "309", "EndPage": "316", "MedlinePgn": "309-16"}, "Abstract": {"AbstractText": ["Complementary and alternative medicine (CAM) therapies present a growing information management challenge for physicians because nearly 40% of their patients may be using and another 50% may be considering use of CAM as part of their healthcare regimen. The National Health Statistics Reports for 2007 described the most commonly used nonvitamin, nonmineral therapy as natural products (eg, herbals at 17.7%). More than 5% of children under the age of 18 years used CAM for allergic conditions including asthma. The amount and quality of information available and concerns about liability risk represent a challenge for most physicians. This review focuses on considerations for approaching a CAM-related consultation, incorporating legal and logistic factors affecting how such an encounter should be approached. A 10-step process is presented that addresses different components of CAM consultations and what should be documented. Access to timely, high-quality information regarding product specific efficacy and safety data, as found in the Natural Medicines Comprehensive Database, is needed to support CAM consultation efficiently. Understanding of serious adverse events associated with CAM is limited; an international need exists for improved safety surveillance and information sharing. Allergy-immunology, as a specialty with expertise in adverse drug reaction evaluation and management, has a unique opportunity to support enhanced CAM-related adverse events evaluations, reporting, and research."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Vaccine Healthcare Centers Network, Allergy-Immunology Department, Walter Reed Army Medical Center, Washington, DC, USA."}], "Identifier": [], "LastName": "Engler", "ForeName": "Renata J M", "Initials": "RJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "With", "ForeName": "Catherine M", "Initials": "CM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gregory", "ForeName": "Philip J", "Initials": "PJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jellin", "ForeName": "Jeff M", "Initials": "JM"}], "GrantList": [{"GrantID": "K07 AT005463", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Allergy Clin Immunol", "NlmUniqueID": "1275002", "ISSNLinking": "0091-6749"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}], "CommentsCorrectionsList": [{"RefSource": "J Allergy Clin Immunol. 2009 Feb;123(2):317-8. doi: 10.1016/j.jaci.2008.12.1112", "PMID": "19203655"}], "MeshHeadingList": [{"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["adverse effects", "ethics", "legislation & jurisprudence"], "DescriptorName": "Complementary Therapies"}, {"QualifierName": ["ethics"], "DescriptorName": "Health Personnel"}, {"QualifierName": ["ethics", "legislation & jurisprudence"], "DescriptorName": "Health Services Needs and Demand"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Hypersensitivity"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "Conflicts of Interest: There are no conflicts of interest to report."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United states, 2007. Natl Health Stat Report. 2008;(12):1\u201323.", "ArticleIdList": ["19361005"]}, {"Citation": "U.S. Food and Drug Administration. Dietary supplement and nonprescription drug consumer protection act. 2007"}, {"Citation": "Dennehy CE, Tsourounis C, Horn AJ. Dietary supplement-related adverse events reported to the california poison control system. Am J Health Syst Pharm. 2005;62(14):1476\u20131482. doi: 10.2146/ajhp040412.", "ArticleIdList": ["10.2146/ajhp040412", "15998927"]}, {"Citation": "Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Drug Saf. 2007;30(5):367\u2013373.", "ArticleIdList": ["17472416"]}, {"Citation": "Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. the CONSORT statement. JAMA. 1996;276(8):637\u2013639.", "ArticleIdList": ["8773637"]}, {"Citation": "Ebrahim S, Clarke M. STROBE: New standards for reporting observational epidemiology, a chance to improve. Int J Epidemiol. 2007;36(5):946\u2013948. doi: 10.1093/ije/dym185.", "ArticleIdList": ["10.1093/ije/dym185", "17890280"]}, {"Citation": "Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343(25):1833\u20131838. doi: 10.1056/NEJM200012213432502.", "ArticleIdList": ["10.1056/NEJM200012213432502", "11117974"]}, {"Citation": "Gryzlak BM, Wallace RB, Zimmerman MB, Nisly NL. National surveillance of herbal dietary supplement exposures: The poison control center experience. Pharmacoepidemiol Drug Saf. 2007;16(9):947\u2013957. doi: 10.1002/pds.1445.", "ArticleIdList": ["10.1002/pds.1445", "PMC2265591", "17613175"]}, {"Citation": "U.S. Consumer Product Safety Commission. Requirements under the poison prevention packaging act 16 CFR 1700. 2001"}, {"Citation": "Hung SK, Hillier S, Ernst E. Case reports of adverse effects of herbal medicinal products (HMPs): A quality assessment. Phytomedicine. 2011;18(5):335\u2013343. doi: 10.1016/j.phymed.2010.07.007.", "ArticleIdList": ["10.1016/j.phymed.2010.07.007", "20739165"]}, {"Citation": "Panis B, Wong DR, Hooymans PM, De Smet PA, Rosias PP. Recurrent toxic hepatitis in a caucasian girl related to the use of shou-wu-pian, a chinese herbal preparation. J Pediatr Gastroenterol Nutr. 2005;41(2):256\u2013258.", "ArticleIdList": ["16056110"]}, {"Citation": "Humberston CL, Akhtar J, Krenzelok EP. Acute hepatitis induced by kava kava. J Toxicol Clin Toxicol. 2003;41(2):109\u2013113.", "ArticleIdList": ["12733846"]}, {"Citation": "Morris MC, Donoghue A, Markowitz JA, Osterhoudt KC. Ingestion of tea tree oil (melaleuca oil) by a 4-year-old boy. Pediatr Emerg Care. 2003;19(3):169\u2013171. doi: 10.1097/01.pec.0000081241.98249.7b.", "ArticleIdList": ["10.1097/01.pec.0000081241.98249.7b", "12813303"]}, {"Citation": "Koren G, Randor S, Martin S, Danneman D. Maternal ginseng use associated with neonatal androgenization. JAMA. 1990;264(22):2866.", "ArticleIdList": ["2232076"]}, {"Citation": "Jones TK, Lawson BM. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr. 1998;132(3):550\u2013552. doi: 10.1016/S0022-3476(98)70041-1.", "ArticleIdList": ["10.1016/S0022-3476(98)70041-1", "9544922"]}, {"Citation": "Chan B, Ui LQ, Ming TP, et al. Methemoglobinemia after ingestion of chinese herbal medicine in a 9-day-old infant. Clin Toxicol (Phila) 2007;45(3):281\u2013283. doi: 10.1080/15563650601118028.", "ArticleIdList": ["10.1080/15563650601118028", "17453881"]}, {"Citation": "Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356(5):479\u2013485. doi: 10.1056/NEJMoa064725.", "ArticleIdList": ["10.1056/NEJMoa064725", "17267908"]}, {"Citation": "Martin I, Lopez-Vilchez MA, Mur A, et al. Neonatal withdrawal syndrome after chronic maternal drinking of mate. Ther Drug Monit. 2007;29(1):127\u2013129. doi: 10.1097/FTD.0b013e31803257ed.", "ArticleIdList": ["10.1097/FTD.0b013e31803257ed", "17304161"]}, {"Citation": "Rafaat M, Leung AK. Garlic burns. Pediatr Dermatol. 2000;17(6):475\u2013476.", "ArticleIdList": ["11123784"]}, {"Citation": "Garty BZ. Garlic burns. Pediatrics. 1993;91(3):658\u2013659.", "ArticleIdList": ["8441577"]}, {"Citation": "Darben T, Cominos B, Lee CT. Topical eucalyptus oil poisoning. Australas J Dermatol. 1998;39(4):265\u2013267.", "ArticleIdList": ["9838728"]}, {"Citation": "Bagheri H, Broue P, Lacroix I, et al. Fulminant hepatic failure after herbal medicine ingestion in children. Therapie. 1998;53(1):82\u201383.", "ArticleIdList": ["9773106"]}, {"Citation": "Schmid T, Turner D, Oberbaum M, Finkelstein Y, Bass R, Kleid D. Respiratory failure in a neonate after folk treatment with broom bush (retama raetam) extract. Pediatr Emerg Care. 2006;22(2):124\u2013126. doi: 10.1097/01.pec.0000199560.96356.b0.", "ArticleIdList": ["10.1097/01.pec.0000199560.96356.b0", "16481932"]}, {"Citation": "Bhowmick SK, Hundley OT, Rettig KR. Severe hypernatremia and hyperosmolality exacerbated by an herbal preparation in a patient with diabetic ketoacidosis. Clin Pediatr (Phila) 2007;46(9):831\u2013834. doi: 10.1177/0009922807303042.", "ArticleIdList": ["10.1177/0009922807303042", "17585008"]}, {"Citation": "Asiri Y. Lead toxicity of an infant from home made herbal remedy. Saudi Pharmaceutical Journal. 2006;14(2)"}, {"Citation": "Corazza M, Lauriola MM, Poli F, Virgili A. Contact vulvitis due to pseudowintera colorata in a topical herbal medicament. Acta Derm Venereol. 2007;87(2):178\u2013179. doi: 10.2340/00015555-0173.", "ArticleIdList": ["10.2340/00015555-0173", "17340033"]}, {"Citation": "Florkowski CM, Elder PA, Lewis JG, et al. Two cases of adrenal suppression following a chinese herbal remedy: A cause for concern? N Z Med J. 2002;115(1153):223\u2013224.", "ArticleIdList": ["12064709"]}, {"Citation": "Roulet M, Laurini R, Rivier L, Calame A. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J Pediatr. 1988;112(3):433\u2013436.", "ArticleIdList": ["3346784"]}, {"Citation": "Khandpur S, Malhotra AK, Bhatia V, et al. Chronic arsenic toxicity from ayurvedic medicines. Int J Dermatol. 2008;47(6):618\u2013621. doi: 10.1111/j.1365-4632.2008.03475.x.", "ArticleIdList": ["10.1111/j.1365-4632.2008.03475.x", "18477160"]}]}], "History": [{"Year": "2008", "Month": "11", "Day": "6"}, {"Year": "2008", "Month": "12", "Day": "24"}, {"Year": "2009", "Month": "1", "Day": "5"}, {"Year": "2009", "Month": "2", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "2", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "3", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2014", "Month": "1", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19203654", "NIHMS493039", "PMC3891367", "10.1016/j.jaci.2009.01.001", "S0091-6749(09)00004-9"]}}], "PubmedBookArticle": []}